Featured Post

Dermatologic Manifestations of Pulmonary Disease

Image
the plague bacteria :: Article Creator Ancestor Of Black Death Has Been Discovered In Bronze-Age Sheep Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.Generate Key Takeaways An ancestor of the bacteria responsible for plague has been found in the tooth of a sheep that lived nearly 4,000 years ago in a Bronze Age human settlement, scientists report in a new preprint study. Millennia later, the apparent descendants of this pathogen would unleash vicious pandemics that claimed millions of human lives, including the 6th-century Justinian plague and the 14th-century Black Death. In tracing the backstories of diseases like plague, this new research highlights the importance of looking not just at ancient human remains, but also the animals around them, the authors say. Most human pathogens have zoonotic origins, a...

2019 Pipeline Insight on the Plague - Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com - Business Wire

DUBLIN--()--The "Plague - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Plague development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the Report

  • The report provides a snapshot of the pipeline development for Plague
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Plague
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Plague
  • The report also covers the dormant and discontinued pipeline projects related to Plague

Reasons to Buy

  • Establish comprehensive understanding of the pipeline activity across this Plague to formulate effective R&D strategies
  • Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Plague therapeutics
  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Companies Mentioned

  • Achaogen Inc.
  • Aradigm Corp.
  • AvidBiotics Corp.
  • Endacea Inc.
  • GlaxoSmithKline PLC
  • iBio Inc.
  • Paratek Pharmaceuticals Inc.
  • Prokarium Ltd.
  • Syntiron LLC
  • Takeda Pharmaceutical Company Ltd.

Topics Covered

1. Report Introduction

2. Plague Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Plague

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/2pj436/2019_pipeline?w=4



https://ift.tt/2UdaFIs

Comments

Popular Posts

Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University

Model Monday's: Diana Moldovan

Navel Orangeworm Plague Might be Growing Out of Control - Growing Produce